What is Cri Du Chat Syndrome?

A rare genetic disorder Cri du chat syndrome (CDCS), commonly known as 5p- (5p minus) syndrome, is characterized by partial deletion of the short arm of chromosome 5. The syndrome names come from the distinctive high-pitched cry of the affected infants, which resembles the cat's cry.

It is a rare genetic disorder characterized by a partial deletion of the short arm of chromosome 5. The genetic basis of this condition involves a deletion in the short arm (p) of chromosome 5. The amount of genetic material lost in this deletion varies, but it usually affects multiple genes, including TERT (telomerase reverse transcriptase) and CTNND2 (catenin delta-2), which are essential for healthy development. The intensity of the symptoms is influenced by the amount of the deletion. This syndrome is estimated to occur in approximately 1 in 15,000 to 50,000 live births. It affects individuals across all ethnicities and both genders, although there is a slightly higher prevalence in females compared to males.¹

Clinical features

High-pitched cry

One of the hallmark features of CDCS is a distinctive, high-pitched cry that sounds like the mewing of a cat. This cry is usually noticeable during the first few weeks of life and results from abnormalities in the larynx and nervous system.

Facial features

Children with this syndrome often have unique facial features such as a head that is smaller than usual is called microcephaly, a face structure that is rounded, and an increased space between the eyes is known as wide-set eyes or hypertelorism. These characteristics may aid in the clinical diagnosis of the illness.

Delayed development

People with Cri Du Chat’s frequently experience developmental delays. These may consist of motor delays and cognitive delays. Motor delays include the inability to accomplish motor milestones including sitting, standing, and walking on time. Cognitive delays impact learning and academic performance by mild to severe intellectual disorders.

Other physical and cognitive symptoms

• Hypotonia: Low muscle tone, impairs coordination and movement
• Growth retardation: Slower growth rates, lead to shorter stature
• Behavioural problems: Hyperactivity, aggression, and self-injurious behaviours
• Speech and language delays: Difficulty in communicating and developing speech^2,3

Diagnosis

Genetic testing is a crucial tool used in the diagnosis of this condition. Techniques consist

1. Karyotyping: A lab method for identifying large deletions using a microscope to see chromosomes
2. Fluorescence In Situ Hybridization (FISH): A more accurate method that can be used to identify minor deletions, FISH uses fluorescent probes to identify specific DNA sequences on chromosomes
3. Microarray analysis: This high-resolution technique can detect even the smallest chromosomal deletions and duplications by comparing the patient's DNA to a reference genome³

Clinical examination and family history

In-depth clinical examinations that concentrate on the distinctive physical and developmental characteristics of the syndrome are also crucial. Determining if the deletion happened de novo (newly in the patient) or is inherited can be accomplished by reviewing the family history. To help families understand the risks associated with future pregnancies and inheritance patterns, genetic counselling is frequently advised.³

Immunodeficiency in Cri Du Chat syndrome

Prevalence of immunodeficiency in Cri Du Chat Syndrome

Case reports and clinical observations

Clinical observations and case reports provide valuable insights into the prevalence and nature of immunodeficiencies in CDCS. Several case reports have documented instances where children with CDCS presented with recurrent infections, which prompted investigations that revealed underlying immunodeficiencies. 

For example, a case report in the European Journal of Pediatrics described a child with CDCS who suffered from recurrent respiratory infections and was subsequently diagnosed with selective IgA deficiency. Another report highlighted a CDCS patient with recurrent sinopulmonary infections, who was found to have hypogammaglobulinemia, a condition indicated by low levels of immunoglobulins.⁴

Additionally, a review in the Journal of Medical Genetics discussed various case studies and clinical observations, emphasizing that while immunodeficiency is not a hallmark of CDCS, it is a significant comorbidity that warrants attention in clinical management. Furthermore, a thorough analysis published in the Journal of Medical Genetics covered a range of case studies and clinical observations, highlighting the fact that immunodeficiency is not a defining feature of CDCS.⁵

Studies and statistics

The prevalence of immunodeficiency in individuals with CDCS is not well-documented due to the rarity of the syndrome and the focus primarily on its neurological and developmental aspects. However, emerging research indicates that immunodeficiencies may be more common in CDCS than previously recognized. A study published in the Journal of Clinical Immunology reported that a subset of patients with CDCS exhibited various forms of immunodeficiency, including antibody deficiencies and T-cell abnormalities. The study suggested that approximately 10-15% of individuals with CDCS might have some form of immune dysfunction, although this estimate requires further validation through larger, more comprehensive studies[6].

Types of immunodeficiencies in Cri Du Chat syndrome

1. Primary immunodeficiencies

These are internal defects of the immune system that are present from birth. In individuals with CDCS, the following types of primary immunodeficiencies have been observed:

• Antibody deficiencies: These include conditions such as selective IgA deficiency and hypogammaglobulinemia. Selective IgA deficiency is characterized by undetectable levels of IgA in the blood, while hypogammaglobulinemia involves lower-than-normal levels of all types of immunoglobulins (IgG, IgA, IgM)
• T-cell deficiencies: Though less frequently reported in CDCS, certain patients exhibit decreased T-cell numbers or function, leading to increased susceptibility to infections⁶

2. Secondary immunodeficiencies

Secondary immunodeficiencies in CDCS may arise due to other health issues or treatments. These include:

• Malnutrition: Poor nutritional status can compromise the immune system’s ability to function effectively
• Chronic infections: Persistent infections can deplete the body’s immune resources
• Medications: Long-term use of immunosuppressive medications, such as corticosteroids for other comorbid conditions, can lead to secondary immunodeficiency
• Environmental factors: Exposure to pollutants and other environmental factors can also impair immune function⁷

Mechanisms linking Cri Du Chat syndrome and immunodeficiency

1. Genetic mutations affecting the immune system

The genetic basis of CDCS involves deletions on chromosome 5p, which may include genes crucial for immune system development and function. These deletions can lead to a variety of immune system deficiencies. Specific genes on chromosome 5p that are involved in immune regulation and development include:

• TERT (Telomerase Reverse Transcriptase): While primarily associated with cellular ageing, mutations in TERT can also impact the immune system’s capacity to regenerate and respond to infections
• CTNND2 (Catenin Delta-2): Mutations in this gene can influence neural development and potentially impact immune system interactions via neural-immune system communication pathways⁸

2. Possible disruptions in immune regulatory genes on chromosome 5p

The deletion of specific regions on chromosome 5p can disrupt the normal function of immune regulatory genes, leading to immunodeficiency. For example:

• DNA damage and repair genes: Genes involved in the repair of DNA damage, if deleted or mutated, can lead to increased susceptibility to infections and immune deficiencies due to the accumulation of genetic damage in immune cells
• Regulatory pathways: Disruption in genes that regulate immune responses can lead to either hyperactivity or underactivity of the immune system, resulting in increased susceptibility to infections or autoimmune conditions^9,10

Clinical management

Monitoring and assessment

Regular immune function tests

Regular monitoring of immune function is crucial for individuals with Cri Du Chat Syndrome (CDCS) who are at risk for immunodeficiency. This includes:

• Immunoglobulin levels: Measuring serum levels of IgG, IgA, and IgM to identify deficiencies. Studies suggest that regular assessment can help detect and manage immunoglobulin deficiencies early, thereby preventing severe infections
• White blood cell counts: Complete blood counts (CBC) with differential to monitor for abnormalities in white blood cell counts, which can indicate underlying immunodeficiency¹¹

Monitoring for infections and other immune-related complications

Regular clinical evaluations are essential to monitor for signs of infections, such as recurrent respiratory or gastrointestinal infections. This proactive approach helps in early identification and treatment of infections, thereby reducing morbidity in CDCS patients¹²

Treatment strategies

Immunoglobulin replacement therapy

Immunoglobulin replacement therapy (IRT) is a cornerstone of treatment for patients identified with antibody deficiencies. IRT helps in preventing infections by providing necessary antibodies that the patient's body cannot produce in sufficient quantities

Antibiotic prophylaxis

Prophylactic antibiotics may be prescribed to prevent recurrent bacterial infections, particularly in patients with significant immunodeficiencies. This approach helps in reducing the frequency and severity of infections.

Vaccination considerations

Vaccinations are critical for preventing infections in immunocompromised patients. However, live vaccines may be contraindicated in patients with significant immunodeficiency. It is essential to tailor the vaccination schedule to the individual's immune status and follow guidelines from immunologists.^12,13

Future directions

Current research efforts

Research on Cri Du Chat Syndrome (CDCS) and its associated immunodeficiencies is ongoing, focusing on several key areas:

1. Genetic studies: Advanced genomic techniques, such as whole-genome sequencing and CRISPR gene editing, are being utilized to better understand the specific genetic deletions on chromosome 5p and their effects on the immune system. These studies aim to identify critical genes involved in immune regulation that are impacted by chromosomal deletions
2. Immunological profiling: Researchers are conducting detailed immunological assessments of CDCS patients to map out the specific types of immunodeficiencies prevalent in this population. This includes studies on immunoglobulin levels, T-cell function, and other immune parameter
3. Clinical trials and treatments: Clinical trials are exploring new treatment strategies, including immunoglobulin replacement therapies and novel immunomodulatory drugs. These trials aim to improve the quality of life and clinical outcomes for CDCS patients with immunodeficiency¹¹

FAQs

What causes Cri Du Chat Syndrome?

CDCS is caused by a partial deletion of the short arm of chromosome 5 (5p), which results in the loss of several genes critical for normal development and function.

How is Cri Du Chat Syndrome diagnosed?

Diagnosis typically involves genetic testing methods such as karyotyping, fluorescence in situ hybridization (FISH), and microarray analysis to detect chromosomal deletions.

What types of immunodeficiencies are associated with CDCS?

Common immunodeficiencies include antibody deficiencies (e.g., selective IgA deficiency) and, less commonly, T-cell deficiencies. These can lead to increased susceptibility to infections.

How is immunodeficiency managed in CDCS patients?

Management includes regular immune function tests, immunoglobulin replacement therapy, antibiotic prophylaxis, tailored vaccination schedules, and supportive therapies like nutritional support and physical therapy.

What role do specialists play in managing CDCS?

A multidisciplinary team including geneticists, immunologists, and paediatricians is essential for providing comprehensive care, addressing both the genetic and immunological aspects of CDCS.

Summary

• Cri Du Chat syndrome (CDCS): A genetic disorder caused by a deletion on chromosome 5p, characterized by a distinctive cry, facial features, developmental delays, and potential immunodeficiencies
• Immunodeficiencies in CDCS: Includes primary immunodeficiencies like antibody deficiencies and secondary immunodeficiencies due to other health issues or treatments
• Monitoring and assessment: Regular immune function tests and vigilant monitoring for infections are crucial for managing immunodeficiency in CDCS patients
• Treatment strategies: Include immunoglobulin replacement therapy, antibiotic prophylaxis, tailored vaccination plans, and supportive therapies
• Multidisciplinary approach: Involves coordinated care among geneticists, immunologists, and paediatricians to ensure comprehensive management of CDCS
• Research and future directions: Focus on understanding genetic mechanisms, improving immunological profiling, and developing new treatments